Myriad Genetics, Inc. Profit Up; at Ease with ’10 Street View

Reuters -- Myriad Genetics's fourth-quarter income from continuing operations rose 71 percent and said it was comfortable with the current market estimates for fiscal 2010, sending shares up 7 percent after the bell.